Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Biostatistics for clinician researchers 2: Survival and K-M analysis

Share :

ecancer Kathmandu 2023 Research Methods Workshop

28 - 29 Oct 2023
Published: 29 Oct 2023
Views: 54
Rating:
Save
Dr Martin Stockler - Sidney University, Australia

Dr Martin Stockler speaks at the ecancer Kathmandu 2023 Research Methods Workshop, which was held in Nepal, on 28th and 29th of October 2023.

Related Videos

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...
Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )
25 Jan 2024
OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
The Vietnam National Cancer Institute’s efforts in improving cancer care in...
Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam ( Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute )
5 Sep 2023
Time toxicity: the burden on cancer patients
Dr Arjun Gupta - University of Minnesota, Minneapolis, USA
Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )
24 May 2023
The time toxicity of cancer care
Dr Arjun Gupta - University of Minnesota, Minneapolis, USA
The time toxicity of cancer care ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )
24 May 2023
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )
9 May 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Choosing Wisely in medical oncology
Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya
Choosing Wisely in medical oncology ( Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya )
25 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation